FAFGX
Price
$89.46
Change
+$0.54 (+0.61%)
Updated
Dec 3 closing price
Net Assets
338.91B
MSGUX
Price
$52.90
Change
+$1.22 (+2.36%)
Updated
Dec 3 closing price
Net Assets
4.19B
Interact to see
Advertisement

FAFGX vs MSGUX

Header iconFAFGX vs MSGUX Comparison
Open Charts FAFGX vs MSGUXBanner chart's image
American Funds Growth Fund of Amer 529F2
Price$89.46
Change+$0.54 (+0.61%)
VolumeN/A
Net Assets338.91B
Morgan Stanley Inst Growth C
Price$52.90
Change+$1.22 (+2.36%)
VolumeN/A
Net Assets4.19B
FAFGX vs MSGUX Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FAFGX has more cash in the bank: 339B vs. MSGUX (4.19B). FAFGX pays higher dividends than MSGUX: FAFGX (0.49) vs MSGUX (0.00). FAFGX was incepted earlier than MSGUX: FAFGX (5 years) vs MSGUX (11 years). MSGUX (1.62) is less costly to investors than FAFGX (0.40). MSGUX is a more actively managed with annual turnover of: 39.00 vs. FAFGX (25.00). FAFGX has a lower initial minimum investment than MSGUX: FAFGX (250) vs MSGUX (1000). MSGUX annual gain was more profitable for investors over the last year : 20.15 vs. FAFGX (8.19). FAFGX return over 5 years is better than : 34.63 vs. MSGUX (-37.81).
FAFGXMSGUXFAFGX / MSGUX
Total Expense Ratio0.401.6225%
Annual Report Gross Expense Ratio0.401.6225%
Fund Existence5 years11 years-
Gain YTD20.38825.80379%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets339B4.19B8,100%
Annual Yield % from dividends0.490.00-
Returns for 1 year8.1920.1541%
Returns for 3 years65.2898.5066%
Returns for 5 years34.63-37.81-92%
Returns for 10 yearsN/A27.10-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NSCCX40.910.62
+1.54%
Nuveen Small-Cap Value Opps C
BMSRX15.100.13
+0.87%
MFS Blended Research Mid Cap Eq R1
BCSAX10.230.08
+0.79%
BlackRock Commodity Strategies Inv A
NBRRX28.700.19
+0.67%
Neuberger Berman M/C Intrinsic Val R3
JDEAX49.440.13
+0.26%
JPMorgan US Research Enhanced Equity A